Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation

Biology of Blood and Marrow Transplantation

Volumn 8, Issue 3, 2002, Pages 139-144

  Alyea, E ^a   Neuberg, D ^a   Mauch, P ^a   Marcus, K ^a   Freedman, A ^a   Webb, I ^a   Anderson, K ^a   Schlossman, R ^a   Fisher, D ^a   Gribben, J ^a   Ritz, J ^a   Soiffer, R ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Bone marrow transplantation; T cell depletion; Total body irradiation

Indexed keywords

ANTIBIOTIC AGENT; CD6 ANTIGEN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HODGKIN DISEASE; HUMAN; IN VITRO STUDY; LIVING DONOR; LYMPHOCYTE DEPLETION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PNEUMONIA; RADIATION DOSE; RECURRENCE RISK; RISK ASSESSMENT; SURVIVAL RATE; T LYMPHOCYTE; TREATMENT OUTCOME; WHOLE BODY RADIATION; ADOLESCENT; AGED; BONE MARROW TRANSPLANTATION; HEMATOLOGIC DISEASE; ISOGRAFT; METHODOLOGY; MIDDLE AGED; RADIATION RESPONSE; RECURRENT DISEASE; STANDARD; SURVIVAL;

ADOLESCENT; ADULT; AGED; BONE MARROW TRANSPLANTATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 0036211191     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1053/bbmt.2002.v8.pm11939603     Document Type: Article

References (19)

1. T-cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission
2. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: Freedom from relapse in the absence of graft-versus-host disease
3. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow
4. Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation
5. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk for relapse associated with T-cell depletion
6. Graft-versus-leukemia reactions after bone marrow transplantation
7. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens
8. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens
9. Design and characteristics of a facility for total-body and large-field irradiation
10. Total body irradiation for bone marrow transplantation
11. Depletion of T cells from human bone marrow using monoclonal antibodies and rabbit complement: A quantitative and functional analysis
12. Non-parametric estimation from incomplete observations
13. Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia
14. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies
15. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation
16. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases
17. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
18. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies